Three minutes to identify what hours of observation may miss.
A wrist-worn, AI-enabled diagnostic platform. Non-invasive.
Results in three minutes.
Designed for the emergency department.
A patient arrives with chest pain. The ECG is non-diagnostic. The first troponin draw is ordered. Then the wait begins — 1 hour, 3 hours, sometimes 6 or more — before serial results confirm or exclude high-grade obstruction. During that window, if a severe coronary occlusion is present, heart muscle is dying.
Infrasensor was designed for that window. It delivers an identification result at the moment the patient arrives — not hours later, when the answer finally emerges from the serial protocol.
Infrasensor is a wrist-worn, AI-enabled diagnostic platform designed to identify severe coronary occlusion in approximately three minutes — non-invasively, at the point of care, as an adjunct to standard of care in the emergency department.
Validated across more than 1,500 patients in multicenter clinical studies.
Peer-reviewed publications in Communications Medicine and European Heart Journal – Digital Health.
350-patient FDA pivotal study currently in execution across five U.S. sites.
For clinicians
Infrasensor integrates into the earliest moments of the ED encounter.
For health systems
For high-volume emergency departments, the cost of the current ACS observation pathway is measured in boarding hours, bed-days, and throughput drag.
Pursuing Class II De Novo FDA approval — submission anticipated 2026.
Contact